<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05617287</url>
  </required_header>
  <id_info>
    <org_study_id>20265</org_study_id>
    <nct_id>NCT05617287</nct_id>
  </id_info>
  <brief_title>An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Perimenopause and Menopause</brief_title>
  <official_title>An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Perimenopause and Menopause</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semaine Health</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Citruslabs</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Semaine Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A combination of synergistic dietary supplements is hypothesized to significantly improve&#xD;
      self-reported measures of menopausal symptoms when compared with a baseline without the&#xD;
      intervention.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 3, 2022</start_date>
  <completion_date type="Actual">January 1, 2023</completion_date>
  <primary_completion_date type="Actual">January 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in perceived discomfort associated with the most common symptoms linked with perimenopause and menopause</measure>
    <time_frame>12 weeks</time_frame>
    <description>Symptoms will be reported by the participant on a scale of perceived discomfort and will include rankings for mood, anxiety, fatigue, sleep quality, hot flashes, and libido.&#xD;
This survey will be based on the widely used and validated Menopause Rating Scale (MRS). The MRS will be modified to increase dynamic range by changing the response gradations from 5 to 7.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Menopause</condition>
  <condition>Menopause Related Conditions</condition>
  <condition>Perimenopausal Disorder</condition>
  <arm_group>
    <arm_group_label>Semaine Supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants are provided with a dietary supplement and are instructed to take 1 capsule per day. Participants are to take the supplement at the same time every day. If forgotten, they are to take it with the next meal. Participants will take a well-being assessment after each month (4 surveys total including the baseline.)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Semaine Menopause Supplement</intervention_name>
    <description>Synergistic Dietary Supplement</description>
    <arm_group_label>Semaine Supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ability to take oral medication and be willing to adhere to the dietary supplement&#xD;
             regimen (1 capsule per day)&#xD;
&#xD;
          -  Moderate self-reported discomfort related to perimenopause or menopause. Participants&#xD;
             will complete the menopause well-being survey and must answer an average of &quot;moderate&quot;&#xD;
             or higher.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current use of medication for high blood pressure or for blood thinning&#xD;
&#xD;
          -  Currently undergoing chemotherapy or has previously been treated for cancer&#xD;
&#xD;
          -  Pregnancy, breastfeeding, or attempting to become pregnant during the study&#xD;
&#xD;
          -  Known allergic reactions to components of the dietary supplement (red clover extract,&#xD;
             olive extract, bergamot extract )&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>57 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Hill</last_name>
    <role>Principal Investigator</role>
    <affiliation>Citruslabs</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matthew Crane</last_name>
    <role>Principal Investigator</role>
    <affiliation>Semaine Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Citruslabs</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>November 7, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2022</study_first_posted>
  <last_update_submitted>April 11, 2023</last_update_submitted>
  <last_update_submitted_qc>April 11, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Menopause</keyword>
  <keyword>Perimenopause</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

